PreTel Overview
- Founded
- 2015
- Status
- Private
- Latest Deal Type
- Grant
- Latest Deal Amount
- $352K
- Investors
- 5
PreTel General Information
Description
Provider of monitoring and decision support methods designed for all stages of pregnancy. The company's monitoring system identifies independent contraction activity of individual regions of the uterus and permits for improved care in the preterm labor patient, managing the progress of labor at the time of delivery and safety to the admiration of induction therapy, enabling hospitals to improve both maternal and neonatal outcomes in the labor and delivery department and avoid unnecessary C-Section deliveries, post-delivery maternal hemorrhage, and expensive neonatal intensive care nursery stays.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
- 871 McCallie Avenue
- Chattanooga, TN 37403
- United States
+1 (423) 000-0000
PreTel Timeline
PreTel Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 01-Jan-2019 | $352K | 00.000 | Completed | Generating Revenue | |
| 4. Early Stage VC | 27-Dec-2017 | 00000 | 00.000 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A) | 15-Mar-2017 | 00.00 | 00.000 | 00.00 | Completed | Generating Revenue |
| 2. Seed Round | 08-Jan-2016 | $375K | $450K | 00000 | Completed | Generating Revenue |
| 1. Seed Round | 30-Mar-2015 | $74.9K | $74.9K | 00000 | Completed | Startup |
PreTel Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed 2 | 000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed | 115,300 | $0.000100 | 5% | $0.65 | $0.65 | 1x | $0.65 | 6.43% |
PreTel Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Marc Finch | Co-Founder & Chief Executive Officer | ||
| Roger Young MD | Co-Founder, Chief Medical Officer & President | ||
| Mark Samuels | Executive Chairman |
PreTel Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Blake Patton | Tech Square Venture Partners | Board Member | 000 0000 |
| David Adair MD | Solas BioVentures | Board Member | 000 0000 |
| Gregg Raybuck | PreTel | Board Member | 000 0000 |
| Mark Samuels | Self | Executive Chairman | 000 0000 |
PreTel Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| Solas BioVentures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Foley Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Tech Square Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| University of Tennessee Research Foundation | Limited Partner | Minority | 000 0000 | 000000 0 |